HomeTXG • NASDAQ
add
10X Genomics Inc
Previous close
$9.20
Day range
$8.95 - $9.42
Year range
$6.78 - $25.65
Market cap
1.16B USD
Avg Volume
4.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 154.88M | 9.84% |
Operating expense | 153.97M | 0.89% |
Net income | -34.36M | 42.69% |
Net profit margin | -22.18 | 47.84% |
Earnings per share | -0.10 | 48.97% |
EBITDA | -40.51M | 19.32% |
Effective tax rate | -2.54% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 426.90M | 14.82% |
Total assets | 903.39M | -2.12% |
Total liabilities | 196.50M | -3.71% |
Total equity | 706.90M | — |
Shares outstanding | 123.13M | — |
Price to book | 1.60 | — |
Return on assets | -13.32% | — |
Return on capital | -15.36% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -34.36M | 42.69% |
Cash from operations | 34.35M | 318.45% |
Cash from investing | -1.89M | -117.80% |
Cash from financing | 422.00K | -74.24% |
Net change in cash | 32.99M | 1,041.88% |
Free cash flow | 36.94M | 2,206.22% |
About
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. Wikipedia
Founded
2012
Headquarters
Website
Employees
1,306
